Heart Test Laboratories Inc (HSCS) Live Share Price, Invest From India

Heart Test Laboratories Inc Stock Performance

as on March 21, 2026 at 6:59 am IST

Day's Low
$2.57
Day's Price Range
$2.67
$2.67
3.75%
Downside
52 Week's Low
52 Week's High
$2.01
52-Week Price Range
$6.47
$2.67
24.72%
Downside
142.32%
Upside

Heart Test Laboratories Inc share price movements today

Previous Close: $2.57
Open: $2.57
Volume: 74.4K
Day's Low - High: $2.57 - $2.67
52 Week Low - High: $2.01 - $6.47

Heart Test Laboratories Inc Historical Returns

1 Month Return: -9.25 %
3 Month Return: + 8.05 %
1 Year Return: -12.37 %
3 Year Return: -97.56 %
5 Year Return: 0 %

Heart Test Laboratories Inc Stock Fundamentals & Key Indicators

Check Heart Test Laboratories Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.2M

EPS (TTM)

-3.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.8M

Revenue (TTM)

8.7K

Profit Margin

0.00%

Return On Equity TTM

-382.32%

Heart Test Laboratories Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Heart Test Laboratories Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Heart Test Laboratories Inc	BUY	$8.2M	NA	NA	0.00%
Boston Scientific Corp.	BUY	$103.7B	82.03%	36.03	14.44%
Stryker Corporation	BUY	$130.0B	45.94%	40.5	12.92%
Abbott Laboratories	BUY	$186.3B	-12.3%	28.81	14.72%
Medtronic Plc	BUY	$111.5B	-26.12%	24.27	13.00%

See all

Stock Returns calculator for Heart Test Laboratories Inc Stock including INR - Dollar returns

The Heart Test Laboratories Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Heart Test Laboratories Inc investment value today

Current value as on today

₹1,01,197

Returns

₹1,197

(+1.2%)

Returns from Heart Test Laboratories Inc Stock

₹8,247 (-8.25%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Heart Test Laboratories Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Heart Test Laboratories Inc. Average target price of $10.6

Heart Test Laboratories Inc Share Price Target

Get share price movements and forecasts by analysts on Heart Test Laboratories Inc.

What analysts predicted

74.81%UPSIDE

Target Price

$10.6

Current Price

$2.67

Analyzed by

8 Analysts

Target

$10.60

Heart Test Laboratories Inc target price $10.6, a slight upside of 74.81% compared to current price of $2.67. According to 8 analysts rating.

Heart Test Laboratories Inc Stock’s Investor Sentiment and Interest

Search interest for Heart Test Laboratories Inc Stock has increased by 156% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 20, 2026 to March 22, 2026

Change:156% versus previous 30 day period

Heart Test Laboratories Inc Quarterly Profit & Loss

All numbers in Millions USD

	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Total Revenue	0	0	-	-	-	-	0	0	0	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-1	-1	-1	-2	-1	-2	-1	-1	-2	-1
EBITDA	-1	-1	-1	-1	-1,985	-2	-1	-1	-2	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	-2	-2	-2	-2	-2	-2	-1
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-1	-1	-1	-2	-2	-2	-2	-2	-2	-1,985
Net Profit Margin	-44830.21%	-11182.39%	0.00%	0.00%	0.00%	0.00%	-48145.49%	-108157.58%	-97179.37%	0.00%

Heart Test Laboratories Inc Annual Profit & Loss

All numbers in Millions USD

	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025
Total Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Operating Income	-3	-2	-4	-6	-6	-8
EBITDA	-3	-2	-4	-6	-6	-8
Interest Expense	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0
Income Before Tax	-3	-2	-4	-6	-6	-8
Income Tax Expense	0	0	0	484	0	-
Net Income	-3	-2	-4	-6	-6	-8
Net Profit Margin	-5937.99%	-9577.29%	-33592.57%	-123384.27%	-35511.87%	-201499.52%

Heart Test Laboratories Inc Quarterly Cash Flow

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Net Income	-1	-1	-2	-4,132	-2	-2	-2	-2,350	-4,038
Operating Cash Flow	-2	-1	-2	-2	-1	-1	-1	-2,334	-1
Investing Cash Flow	0	0	0	0	0	0	0	-15	0
Financing Cash Flow	9	0	0	1	0	0	3	1,508	2
Change in Cash	6	-1	-1	0	-1	-1	1	-841	1,445

Heart Test Laboratories Inc Annual Cash Flow

All numbers in Millions USD

	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025
Net Income	-2	-4	-6	-6	-8
Operating Cash Flow	-2	-3	-5	-6	-7
Investing Cash Flow	0	0	0	0	0
Financing Cash Flow	2	3	6	10	2
Change in Cash	0	0	0	4	-4

Global Institutional Holdings in Heart Test Laboratories Inc

Funds	Holdings
Vanguard Group Inc	0.58%
UBS Group AG	0%
Advisory Services Network, LLC	0.32%
Advisor Group Holdings, Inc.	0%
Tower Research Capital LLC	0.05%

See all

Insights on Heart Test Laboratories Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.9K → 2.41K (in $), with an average increase of 21.5% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 3.9% return, outperforming this stock by 101.4%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 17.1% return, outperforming this stock by 29.5%
NEGATIVE IMPACT
Price Dip
In the last 3 years, HSCS stock has moved down by -97.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -2.05M → -1.98B (in $), with an average decrease of 42181.9% per quarter

About Heart Test Laboratories Inc

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Organisation	Heart Test Laboratories Inc
Headquarters	550 Reserve Street, Southlake, TX, United States, 76092
CEO	Mr. Andrew Simpson
E-voting on shares	Click here to vote

Key Management of Heart Test Laboratories Inc

Name	Title
Mr. Andrew Simpson	CEO, President & Chairman of the Board of Directors
Mr. Mark T. Hilz	COO, Secretary & Director

FAQs

What is Heart Test Laboratories Inc share price today?

Heart Test Laboratories Inc share price today is $2.67 as on March 21, 2026 at 1:29 am IST at the close of the market. Heart Test Laboratories Inc share today touched a day high of $2.67 and a low of $2.57.

What is the 52 week high and 52 week low for Heart Test Laboratories Inc share?

Heart Test Laboratories Inc share touched a 52 week high of $6.47 on July 10, 2025 and a 52 week low of $2.01 on November 21, 2025. Heart Test Laboratories Inc stock price today i.e. March 21, 2026 at 1:29 am IST is closed at $2.67,which is 58.73% down from its 52 week high and 32.84% up from its 52 week low.

What is Heart Test Laboratories Inc's market capitalisation today?

Heart Test Laboratories Inc market capitalisation is $0.00T as on March 21, 2026 at 1:29 am IST.

How to invest in Heart Test Laboratories Inc Stock (HSCS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Heart Test Laboratories Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Heart Test Laboratories Inc Shares that will get you 0.5618 shares as per Heart Test Laboratories Inc share price of $2.67 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Heart Test Laboratories Inc Stock (HSCS) from India?

Indian investors can start investing in Heart Test Laboratories Inc (HSCS) shares with as little as ₹93.652 or $1 (as of March 22, 2026 at 8:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Heart Test Laboratories Inc stock (as per the Rupee-Dollar exchange rate as on March 22, 2026 at 8:38 pm IST). Based on Heart Test Laboratories Inc share’s latest price of $2.67 as on March 21, 2026 at 1:29 am IST, you will get 3.7453 shares of Heart Test Laboratories Inc. Learn more about fractional shares .